Predicting motor decline and disability in Parkinson disease: A systematic review

Archives of Neurology

Volumn 59, Issue 11, 2002, Pages 1724-1728

  Marras, Connie ^a   Rochon, Paula ^b,c   Lang, Anthony E ^a  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b Kunin Lunenfeld Applied Research Unit and Department of Food and Nutrition Services and Baycrest Centre for Geriatric Care   (Canada)

^c Institute for Clinical Evaluative Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; COHORT ANALYSIS; DISEASE COURSE; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; OUTCOMES RESEARCH; PARKINSON DISEASE; PHYSICAL ACTIVITY; PHYSICAL DISABILITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RATING SCALE; REVIEW; RISK FACTOR;

EID: 0036846580     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.59.11.1724     Document Type: Review

References (20)

1. Hely MA, Morris JG, Traficante R, Reid WG, O'Sullivan DJ, Williamson PM. The Sydney multicentre study of Parkinson's disease: Progression and mortality at 10 years. J Neurol Neurosurg Psychiatry. 1999;67:300-307.
2. Laupacis A, Wells G, Richardson S, Tugwell P, for the Evidence-Based Medicine Working Group. Users' guides to the medical literature, V: How to use an article about prognosis. JAMA. 1994;272:234-237.
3. Cho MK, Bero L. Instruments for assessing the quality of drug studies published in the medical literature. JAMA. 1994;272:101-104.
4. Scigliano G, Musicco M, Soliveri P, et al. Progression and prognosis in Parkinson's disease in relation to concomitant cerebral or peripheral vasculopathy. Adv Neurol. 1996;69:305-309.
5. Starkstein SE, Mayberg HS, Leiguarda R, Preziosi TJ, Robinson RG. A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry. 1992;55:377-382.
6. Hely MA, Morris JG, Reid WG, et al. Age at onset: The major determinant of outcome in Parkinson's disease. Acta Neurol Scand. 1995;92:455-463.
7. Diamond SG, Markham CH, Hoehn MM, McDowell FH, Muenter MD. An examination of male-female differences in progression and mortality of Parkinson's disease. Neurology. 1990;40:763-766.
8. Diamond SG, Markham CH, Hoehn MM, McDowell FH, Muenter MD. Effect of age at onset on progression and mortality in Parkinson's disease. Neurology. 1989;39:1187-1190.
9. Guillard A, Chastang C, Fenelon G. Long-term study of 416 cases of Parkinson disease: Prognostic factors and therapeutic implications [in French]. Rev Neurol (Paris). 1986;142:207-214.
10. Guillard A, Chastang C. Long-term prognostic factors in Parkinson's disease [in French]. Rev Neurol (Paris). 1978;134:341-354.
11. Ferraz HB, Andrade LA, Tumas V, Calia LC, Borges V. Rural or urban living and Parkinson's disease. Arq Neuropsiquiatr. 1996;54:37-41 .
12. Louis ED, Tang MX, Cote L, Alfaro B, Mejia H, Marder K. Progression of parkinsonian signs in Parkinson disease.. Arch Neurol. 1999;56:334-337.
13. Hoehn MM, Yahr MD. Parkinsonism: Onset, progression, and mortality. Neurology. 1967;17:427-442.
14. Jankovic J, Kapadia AS. Functional decline in Parkinson disease. Arch Neurol. 2001;58:1611-1615.
15. Goetz CG, Tanner CM, Stebbins GT, Buchman AS. Risk factors for progression in Parkinson's disease. Neurology. 1988;38:1841-1844.
16. Goetz CG, Stebbins GT, Blasucci LM. Differential progression of motor impairment in levodopa-treated Parkinson's disease. Mov Disord. 2000;15:479-484.
17. Lucking CB, Durr A, Bonifati V, et al. Association between early-onset Parkinson's disease and mutations in the parkin gene. N Engl J Med. 2000;342:1560-1567.
18. Oliveri RL, Zappia M, Annesi G, et al. The parkin gene is not involved in late-onset Parkinson's disease. Neurology. 2001;57:359-362.
19. Kostic V, Przedborski S, Flaster E, Sternic N. Early development of levodopa-induced dyskinesias and response fluctuations in young-onset Parkinson's disease. Neurology. 1991;41(2 pt 1):202-205.
20. Gomez AG, Jorge R, Garcia S, Scipioni O, Gershanik O. Clinical and pharmacological differences in early-versus late-onset Parkinson's disease. Mov Disord. 1997;12:277-284.